{
  "solution_stats": {
    "total_solutions": 3,
    "details": [
      {
        "solution_id": 1,
        "steps_count": 4
      },
      {
        "solution_id": 2,
        "steps_count": 6
      },
      {
        "solution_id": 3,
        "steps_count": 5
      }
    ]
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule9",
              "prover9": "(-(A3 -> A2) -> A4)",
              "prover9_expression": "(-(peer_reviewed(journal, study) -> approved(fda, drug_x)) -> rejected(fda, drug_x))",
              "natural": "Provided that peer review by the journal does not imply FDA approval of drug X, then the FDA rejected drug X."
            },
            {
              "id": "Fact6",
              "prover9": "-A4",
              "prover9_expression": "-rejected(fda, drug_x)",
              "natural": "The FDA did not reject drug X."
            }
          ],
          "conclusion": "(A3 -> A2)",
          "natural": "If the journal peer-reviewed the study, then the FDA approved drug X."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule1",
              "prover9": "(A1 -> A3)",
              "prover9_expression": "(published(research_team, clinical_trial) -> peer_reviewed(journal, study))",
              "natural": "Whenever the research team published the clinical trial, the journal peer-reviewed the study."
            },
            {
              "id": "Derived",
              "prover9": "(A3 -> A2)",
              "prover9_expression": "(peer_reviewed(journal, study) -> approved(fda, drug_x))",
              "natural": "If the journal peer-reviewed the study, then the FDA approved drug X."
            }
          ],
          "conclusion": "(A1 -> A2)",
          "natural": "Provided the research team published the clinical trial, the FDA approved drug X."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A1 -> A2)",
              "prover9_expression": "(published(research_team, clinical_trial) -> approved(fda, drug_x))",
              "natural": "Provided the research team published the clinical trial, the FDA approved drug X."
            },
            {
              "id": "Fact5",
              "prover9": "-A2",
              "prover9_expression": "-approved(fda, drug_x)",
              "natural": "The FDA did not approve drug X."
            }
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that the research team published the clinical trial."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule12",
              "prover9": "(-G -> A1)",
              "prover9_expression": "(-available(market, drug_x) -> published(research_team, clinical_trial))",
              "natural": "If drug X is not available on the market, then the research team published the clinical trial."
            },
            {
              "id": "Derived",
              "prover9": "-A1",
              "prover9_expression": "-published(research_team, clinical_trial)",
              "natural": "It is not the case that the research team published the clinical trial."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is available on the market."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule11",
              "prover9": "(-(-(A8 -> (A5 -> G)) -> A9) -> A11)",
              "prover9_expression": "(-(-(completed(research_team, phase_3_trial) -> (manufactured(company, drug_x) -> available(market, drug_x))) -> suspended(fda, trial)) -> investigated(ethics_board, misconduct))",
              "natural": "Provided that the negation of phase 3 trial completion implying drug X availability does not result in FDA trial suspension, then the ethics board investigated misconduct."
            },
            {
              "id": "Rule2",
              "prover9": "(A11 -> A10)",
              "prover9_expression": "(investigated(ethics_board, misconduct) -> retracted(journal, paper))",
              "natural": "Under the condition that the ethics board investigated misconduct, the journal retracted the paper."
            }
          ],
          "conclusion": "(-(-(A8 -> (A5 -> G)) -> A9) -> A10)",
          "natural": "Should it not hold that the negation of phase 3 trial completion leading to drug X availability implies FDA trial suspension, then the journal retracted the paper."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(-(A8 -> (A5 -> G)) -> A9) -> A10)",
              "prover9_expression": "(-(-(completed(research_team, phase_3_trial) -> (manufactured(company, drug_x) -> available(market, drug_x))) -> suspended(fda, trial)) -> retracted(journal, paper))",
              "natural": "Should it not hold that the negation of phase 3 trial completion leading to drug X availability implies FDA trial suspension, then the journal retracted the paper."
            },
            {
              "id": "Fact4",
              "prover9": "-A10",
              "prover9_expression": "-retracted(journal, paper)",
              "natural": "The journal did not retract the paper."
            }
          ],
          "conclusion": "(-(A8 -> (A5 -> G)) -> A9)",
          "natural": "In the event that completion of the phase 3 trial by the research team does not lead to drug X being available on the market if the company manufactured it, then the FDA suspended the trial."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A8 -> (A5 -> G)) -> A9)",
              "prover9_expression": "(-(completed(research_team, phase_3_trial) -> (manufactured(company, drug_x) -> available(market, drug_x))) -> suspended(fda, trial))",
              "natural": "In the event that completion of the phase 3 trial by the research team does not lead to drug X being available on the market if the company manufactured it, then the FDA suspended the trial."
            },
            {
              "id": "Rule10",
              "prover9": "(-(A8 -> (A5 -> G)) -> -A9)",
              "prover9_expression": "(-(completed(research_team, phase_3_trial) -> (manufactured(company, drug_x) -> available(market, drug_x))) -> -suspended(fda, trial))",
              "natural": "If it is not the case that completing the phase 3 trial by the research team implies drug X availability upon manufacturing, then the FDA did not suspend the trial."
            }
          ],
          "conclusion": "(A8 -> (A5 -> G))",
          "natural": "If the research team completed the phase 3 trial, then the company manufacturing drug X implies drug X is available on the market."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule4",
              "prover9": "(A6 -> A8)",
              "prover9_expression": "(funded(nih, research) -> completed(research_team, phase_3_trial))",
              "natural": "Provided the NIH funded the research, the research team completed the phase 3 trial."
            },
            {
              "id": "Derived",
              "prover9": "(A8 -> (A5 -> G))",
              "prover9_expression": "(completed(research_team, phase_3_trial) -> (manufactured(company, drug_x) -> available(market, drug_x)))",
              "natural": "If the research team completed the phase 3 trial, then the company manufacturing drug X implies drug X is available on the market."
            }
          ],
          "conclusion": "(A6 -> (A5 -> G))",
          "natural": "Assuming the NIH funded the research, then if the company manufactured drug X, drug X becomes available on the market."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule5",
              "prover9": "(A6 | A7)",
              "prover9_expression": "(funded(nih, research) | funded(pharma_company, research))",
              "natural": "Either the NIH funded the research, or the pharma company funded the research."
            },
            {
              "id": "Derived",
              "prover9": "(A6 -> (A5 -> G))",
              "prover9_expression": "(funded(nih, research) -> (manufactured(company, drug_x) -> available(market, drug_x)))",
              "natural": "Assuming the NIH funded the research, then if the company manufactured drug X, drug X becomes available on the market."
            },
            {
              "id": "Rule6",
              "prover9": "(A7 -> (A5 -> G))",
              "prover9_expression": "(funded(pharma_company, research) -> (manufactured(company, drug_x) -> available(market, drug_x)))",
              "natural": "Under the condition that the pharma company funded the research, then manufacturing drug X by the company results in drug X being available on the market."
            }
          ],
          "conclusion": "(A5 -> G)",
          "natural": "Should the company manufacture drug X, then drug X is available on the market."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A5 -> G)",
              "prover9_expression": "(manufactured(company, drug_x) -> available(market, drug_x))",
              "natural": "Should the company manufacture drug X, then drug X is available on the market."
            },
            {
              "id": "Fact3",
              "prover9": "A5",
              "prover9_expression": "manufactured(company, drug_x)",
              "natural": "The company manufactured drug X."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is available on the market."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 4,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule7",
              "prover9": "(-(A13 -> A14) -> A15)",
              "prover9_expression": "(-(compliant(team, regulations) -> certified(irb, protocol)) -> penalized(fda, company))",
              "natural": "If it is not the case that team compliance with regulations leads to IRB certification of the protocol, then the FDA penalized the company."
            },
            {
              "id": "Rule8",
              "prover9": "(-(A13 -> A14) -> -A15)",
              "prover9_expression": "(-(compliant(team, regulations) -> certified(irb, protocol)) -> -penalized(fda, company))",
              "natural": "Should it not hold that team compliance with regulations implies IRB certification of the protocol, then the FDA did not penalize the company."
            }
          ],
          "conclusion": "(A13 -> A14)",
          "natural": "Provided the team is compliant with regulations, the IRB certified the protocol."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A13 -> A14)",
              "prover9_expression": "(compliant(team, regulations) -> certified(irb, protocol))",
              "natural": "Provided the team is compliant with regulations, the IRB certified the protocol."
            },
            {
              "id": "Rule3",
              "prover9": "(A14 -> (A12 -> (A5 -> G)))",
              "prover9_expression": "(certified(irb, protocol) -> (valid(protocol) -> (manufactured(company, drug_x) -> available(market, drug_x))))",
              "natural": "In the event the IRB certified the protocol, then if the protocol is valid, manufacturing drug X by the company leads to drug X being available on the market."
            }
          ],
          "conclusion": "(A13 -> (A12 -> (A5 -> G)))",
          "natural": "Given that the team is compliant with regulations, then if the protocol is valid, the company manufacturing drug X implies drug X is available on the market."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A13 -> (A12 -> (A5 -> G)))",
              "prover9_expression": "(compliant(team, regulations) -> (valid(protocol) -> (manufactured(company, drug_x) -> available(market, drug_x))))",
              "natural": "Given that the team is compliant with regulations, then if the protocol is valid, the company manufacturing drug X implies drug X is available on the market."
            },
            {
              "id": "Fact2",
              "prover9": "A13",
              "prover9_expression": "compliant(team, regulations)",
              "natural": "The team is compliant with regulations."
            }
          ],
          "conclusion": "(A12 -> (A5 -> G))",
          "natural": "If the protocol is valid, then whenever the company manufactured drug X, drug X becomes available on the market."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A12 -> (A5 -> G))",
              "prover9_expression": "(valid(protocol) -> (manufactured(company, drug_x) -> available(market, drug_x)))",
              "natural": "If the protocol is valid, then whenever the company manufactured drug X, drug X becomes available on the market."
            },
            {
              "id": "Fact1",
              "prover9": "A12",
              "prover9_expression": "valid(protocol)",
              "natural": "The protocol is valid."
            }
          ],
          "conclusion": "(A5 -> G)",
          "natural": "Should the company manufacture drug X, then drug X is available on the market."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A5 -> G)",
              "prover9_expression": "(manufactured(company, drug_x) -> available(market, drug_x))",
              "natural": "Should the company manufacture drug X, then drug X is available on the market."
            },
            {
              "id": "Fact3",
              "prover9": "A5",
              "prover9_expression": "manufactured(company, drug_x)",
              "natural": "The company manufactured drug X."
            }
          ],
          "conclusion": "G",
          "natural": "Drug X is available on the market."
        }
      ]
    }
  ]
}